HUE043849T2 - Eljárás pirimidin-1-ol vegyület és annak intermediere elõállítására - Google Patents

Eljárás pirimidin-1-ol vegyület és annak intermediere elõállítására

Info

Publication number
HUE043849T2
HUE043849T2 HUE15829152A HUE15829152A HUE043849T2 HU E043849 T2 HUE043849 T2 HU E043849T2 HU E15829152 A HUE15829152 A HU E15829152A HU E15829152 A HUE15829152 A HU E15829152A HU E043849 T2 HUE043849 T2 HU E043849T2
Authority
HU
Hungary
Prior art keywords
compound
pyrimidin
producing
producing pyrimidin
Prior art date
Application number
HUE15829152A
Other languages
English (en)
Inventor
Yuzo Watanabe
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of HUE043849T2 publication Critical patent/HUE043849T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE15829152A 2014-08-06 2015-08-03 Eljárás pirimidin-1-ol vegyület és annak intermediere elõállítására HUE043849T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462033665P 2014-08-06 2014-08-06

Publications (1)

Publication Number Publication Date
HUE043849T2 true HUE043849T2 (hu) 2019-09-30

Family

ID=55263805

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15829152A HUE043849T2 (hu) 2014-08-06 2015-08-03 Eljárás pirimidin-1-ol vegyület és annak intermediere elõállítására

Country Status (12)

Country Link
US (1) US10065930B2 (hu)
EP (1) EP3178814B1 (hu)
JP (1) JP6283748B2 (hu)
KR (1) KR102325655B1 (hu)
CN (1) CN107074780B (hu)
ES (1) ES2731648T3 (hu)
HU (1) HUE043849T2 (hu)
IL (1) IL250223B (hu)
MX (1) MX366754B (hu)
RU (1) RU2681937C2 (hu)
SG (1) SG11201700603TA (hu)
WO (1) WO2016021539A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113214164B (zh) * 2021-05-20 2022-10-18 广西天铭药业有限公司 一种莱博雷生中间体2,4-二甲基嘧啶-5-醇的合成方法
ES2933074B2 (es) * 2021-07-26 2023-09-29 Moehs Iberica Sl Procedimiento de sintesis de 2,4-dimetilpirimidin-5-ol, nuevos intermedios de dicho procedimiento y uso del producto en la sintesis de lemborexant

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3311703A1 (de) * 1983-03-30 1984-10-04 Bayer Ag, 5090 Leverkusen Harnstoffderivate
DE3431272A1 (de) * 1984-08-25 1986-03-06 Bayer Ag, 5090 Leverkusen Substituierte phenylharnstoffe
JPS6229266A (ja) * 1985-07-29 1987-02-07 Matsushita Graphic Commun Syst Inc 自動利得制御回路
JPH0684359B2 (ja) * 1986-06-11 1994-10-26 帝国化学産業株式会社 2−(p−アルコキシカルボニル)フエニルピリミジン誘導体
JPH0684358B2 (ja) 1986-06-11 1994-10-26 帝国化学産業株式会社 アルキルチオフエニルピリミジン誘導体
JP2655359B2 (ja) * 1990-01-25 1997-09-17 富士写真フイルム株式会社 芳香族求核置換反応による芳香族アミン類、芳香族アルコール類、芳香族チオール類の合成法
SG34208A1 (en) 1995-03-01 1996-12-06 Guy Andrew Vaz Blast and fragment resistant polyurethane boot sole for safety footwear
CA2220036A1 (en) 1995-05-05 1996-11-07 Human Genome Sciences, Inc. Human neuropeptide receptor
US6159605A (en) 1997-02-18 2000-12-12 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Ink-jet recording sheet
US6166193A (en) 1997-07-25 2000-12-26 Board Of Regents, University Of Texas System Polynucleotides encoding MY1 receptor
KR100327888B1 (ko) 1999-07-14 2002-03-09 정숭렬 도로포장 파손촉진 시험장치의 무선제어 시스템
KR100977701B1 (ko) 2001-08-10 2010-08-24 시오노기세이야쿠가부시키가이샤 항바이러스제
PE20081229A1 (es) 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
DK2626350T3 (en) * 2010-09-22 2015-06-29 Eisai R&D Man Co Ltd cyclopropane
BR112014019909B1 (pt) 2012-02-17 2020-01-28 Eisai R&D Man Co Ltd processo para produção de compostos úteis como antagonistas do receptor de orexina-2

Also Published As

Publication number Publication date
WO2016021539A1 (ja) 2016-02-11
EP3178814A4 (en) 2018-04-04
US20170204068A1 (en) 2017-07-20
RU2017102349A3 (hu) 2018-10-18
JPWO2016021539A1 (ja) 2017-04-27
RU2681937C2 (ru) 2019-03-14
KR102325655B1 (ko) 2021-11-15
RU2017102349A (ru) 2018-09-06
CN107074780B (zh) 2020-06-12
EP3178814B1 (en) 2019-04-10
CN107074780A (zh) 2017-08-18
ES2731648T3 (es) 2019-11-18
SG11201700603TA (en) 2017-03-30
MX2017001222A (es) 2017-05-01
IL250223B (en) 2019-05-30
US10065930B2 (en) 2018-09-04
MX366754B (es) 2019-07-23
IL250223A0 (en) 2017-03-30
KR20170035917A (ko) 2017-03-31
EP3178814A1 (en) 2017-06-14
JP6283748B2 (ja) 2018-02-21

Similar Documents

Publication Publication Date Title
HK1247205A1 (zh) 烯丙基苯氧基環磷腈化合物及其製造方法
GB201406151D0 (en) Method
GB201406155D0 (en) Method
SG11201701858SA (en) Optimized method for producing methacrolein
PL3227023T3 (pl) Sposób wytwarzania kropel
IL266044B (en) Method for the production of 3-alkylsulfanyl-2-chloro-n-(1-alkyl-h1-tetrazol-5-yl)-4-trifluoromethyl-benzamides
EP3144337A4 (en) Method for producing polyamide
IL252173A0 (en) Methods for the production of methyl dichlorophosphane
GB201416223D0 (en) Manufacturing method
GB201403470D0 (en) Method
SG11201701326YA (en) Method for producing oligosilane
EP3109246A4 (en) Thiopyranose compound and method for producing same
HK1249098A1 (zh) 用於生產氟美他酚的方法
IL246831B (en) A method for the production of 1-indanols and 1-indanamines
IL252029A0 (en) A method for the production of a thialkyl trifluoromethyl compound
SG11201701075UA (en) Method for producing dip-formed article, and dip-formed article
IL250223B (en) A method for the preparation of the pyrimidine-1-ol compound, and its intermediates
IL255093A0 (en) A method for the production of levoglucosenon
PL3511315T3 (pl) Sposób wytwarzania n-metylo-para-anizydyny
PL3299394T3 (pl) Sposób wytwarzania zmodyfikowanych ksylopolisacharydów
GB201601558D0 (en) Method for producing 3-hydroxypropionamide
GB201710285D0 (en) Method for producing nitrogen-containing pentafluorosulfanylbenzene compound
EP3202756A4 (en) Polyfluoroalkylallyl compound and method for producing same
PL3105029T3 (pl) Sposób wytwarzania części
GB2527740B (en) Manufacturing method